Manufacturing Authorization
Zellwerk is GMP compliant according to EU Directive 2003/94EC and has the manufacturing authorization in accordance with § 13 of German Drug Act for bulk production of different human cells (eg T cells, NK cells and MSC) for ATMP manufacturing (Advanced Therapeutic Medicinal Product) to be used in clinical trials.